author-photo

Martin Wiselka

Leicester Royal Infirmary
University Hospitals of Leicester NHS Trust

83

Papers

2143

Citations

Citation Trend

Filter By

Papers (83) Sort By

Journal Conference Others

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.

2021 The Lancet
Show All
- Source
- Cite
- Save
Citations (13)
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.

2021 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (36)
Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT

2021
Show All
- Source
- Cite
- Save
Citations (0)
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study.

2021 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (48)
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.

2021
Show All
- Source
- Cite
- Save
Citations (29)
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK.

2021 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (15)
A prenylated dsRNA sensor protects against severe COVID-19.

2021 Science
Show All
- Source
- Cite
- Save
Citations (3)
Implementation of the LOOP pathway-a framework for the management of ocular tuberculosis across the United Kingdom?

2021 Eye
Show All
- Source
- Cite
- Save
Citations (0)
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

2021 The Lancet
Show All
- Source
- Cite
- Save
Citations (0)
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 The Lancet
Show All
- Source
- Cite
- Save
Citations (341)